Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
Clinical trial NCT05371054 · COMPLETED
Trial details
- NCT number
- NCT05371054
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2024-07-22
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.